Literature DB >> 5844232

Primary cutaneous tuberculosis resulting from mouth-to-mouth respiration.

K M Heilman, C Muschenheim.   

Abstract

Entities:  

Mesh：

Year:  1965        PMID： 5844232     DOI： 10.1056/NEJM196511042731908

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Primary inoculation tuberculosis after an accidental scalpel injury.

Authors:  D Huang; H Yin
Journal:  Infection       Date:  2013-03-07       Impact factor: 3.553

2.  Part 12: Education, implementation, and teams: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.

Authors:  Jasmeet Soar; Mary E Mancini; Farhan Bhanji; John E Billi; Jennifer Dennett; Judith Finn; Matthew Huei-Ming Ma; Gavin D Perkins; David L Rodgers; Mary Fran Hazinski; Ian Jacobs; Peter T Morley
Journal:  Resuscitation       Date:  2010-10       Impact factor: 5.262

Review 3. 

Authors:  J P Nolan; C D Deakin; J Soar; B W Böttiger; G Smith; M Baubin; B Dirks; V Wenzel
Journal:  Notf Rett Med       Date:  2006-02-01       Impact factor: 0.826

4.  Tuberculosis masquerading as oral malignancy.

Authors:  S Kannan; Purvi Thakkar; Anil K Dcruz
Journal:  Indian J Med Paediatr Oncol       Date:  2011-07

Review 5.  Quantity and Quality of Inhaled Dose Predicts Immunopathology in Tuberculosis.

Authors:  Kevin P Fennelly; Edward C Jones-López
Journal:  Front Immunol       Date:  2015-06-29       Impact factor: 7.561

6.  Cutaneous inoculation tuberculosis in a healthcare worker: Case report and literature review.

Authors:  F Soto-Febres; J Ballena-López; D Alva; A Riboty; R León; J Chang; G Pérez-Lazo; J Hidalgo
Journal:  IDCases       Date:  2020-05-07

7.  2005 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Part 2: Adult basic life support.

Authors: 
Journal:  Resuscitation       Date:  2005 Nov-Dec       Impact factor: 5.262
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.